{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:40:45Z","timestamp":1787060445327,"version":"build-2736575974"},"reference-count":80,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1124\/dmd.124.001844","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T15:15:52Z","timestamp":1721661352000},"page":"1039-1047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Shining a Light on Inflammation as a Critical Modulator of Drug Metabolism"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4273-2261","authenticated-orcid":false,"given":"Edward T.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.124.001844_bib1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.freeradbiomed.2007.12.010","article-title":"Roles of nitric oxide in inflammatory downregulation of human cytochromes P450","volume":"44","author":"Aitken","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/dmd.124.001844_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/dmd.107.015511","article-title":"Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes","volume":"35","author":"Aitken","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001844_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1124\/dmd.124.001844_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2006.11.072","article-title":"Effect of interleukin-6 neutralization on CYP3A11 and metallothionein-1\/2 expressions in arthritic mouse liver","volume":"558","author":"Ashino","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0022-3565(24)35029-3","article-title":"Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent","volume":"290","author":"Barclay","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001844_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1124\/dmd.119.089961","article-title":"Nitric Oxide Mediated Degradation of CYP2A6 via the Ubiquitin-Proteasome Pathway in Human Hepatoma Cells","volume":"48","author":"Cerrone","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001844_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bcp.2008.10.029","article-title":"TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease","volume":"77","author":"Chaluvadi","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0026-895X(25)08588-8","volume":"47","author":"Chen","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0006-2952(92)90047-M","article-title":"Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat","volume":"44","author":"Chen","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib10","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0021-9258(18)34933-0","article-title":"Purification and characterization of two constitutive forms of rat liver microsomal cytochrome P-450","volume":"257","author":"Cheng","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.124.001844_bib11","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1124\/jpet.103.057174","article-title":"Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin","volume":"307","author":"Cheng","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001844_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jcph.1093","article-title":"Disease\u2013Drug Interactions in Inflammatory States via Effects on CYP-Mediated Drug Clearance","volume":"58","author":"Coutant","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0026-895X(25)09448-9","article-title":"Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver","volume":"38","author":"Craig","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0022-3565(24)38770-1","article-title":"Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor alpha-deficient mice upon lipopolysaccharide and clofibrate challenges","volume":"296","author":"Cui","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001844_bib15","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1016\/S0021-9258(19)43661-2","article-title":"Neonatal imprinting of liver microsomal hydroxylation and reduction of steroids","volume":"248","author":"Einarsson","year":"1973","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.124.001844_bib16","unstructured":"FDA (2023) Drug-Drug Interaction Assessment for Therapeutic Proteins. Guidance for Industry, pp 1\u20138."},{"key":"10.1124\/dmd.124.001844_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0026-895X(24)23065-0","article-title":"Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes","volume":"60","author":"Ferrari","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib18","first-page":"1121","article-title":"CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS-induced lipid peroxidation and inflammation","volume":"45","author":"Gao","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1124\/dmd.124.001844_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0006-291X(86)90912-5","article-title":"Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice","volume":"136","author":"Ghezzi","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.124.001844_bib20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/iai.54.3.837-840.1986","article-title":"Role of interleukin-1 in the depression of liver drug metabolism by endotoxin","volume":"54","author":"Ghezzi","year":"1986","journal-title":"Infect Immun"},{"key":"10.1124\/dmd.124.001844_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0006-2952(76)90226-4","article-title":"Hepatic microsomal drug metabolism after administration of endotoxin in rats","volume":"25","author":"Gorodischer","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.ph.45.030183.000411","article-title":"Sex steroid induced changes in hepatic enzymes","volume":"45","author":"Gustafsson","year":"1983","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/dmd.124.001844_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/abbi.2000.1772","article-title":"Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-kappaB binding at the transcription start site","volume":"377","author":"Iber","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.124.001844_bib24","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1073\/pnas.90.23.11147","article-title":"Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants","volume":"90","author":"Khatsenko","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.124.001844_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcp.2011.04.016","article-title":"Selective role for tumor necrosis factor-alpha, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen","volume":"82","author":"Kinloch","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib26","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1016\/S0021-9258(18)34356-4","article-title":"Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits","volume":"257","author":"Koop","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.124.001844_bib27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1074\/jbc.M708821200","article-title":"Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins","volume":"283","author":"Lee","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.124.001844_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.113.209841","article-title":"Nitric oxide and interleukin-1beta stimulate the proteasome-independent degradation of the retinoic acid hydroxylase CYP2C22 in primary rat hepatocytes","volume":"348","author":"Lee","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001844_bib29","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/dmd.108.026187","article-title":"Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures","volume":"37","author":"Lee","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001844_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.freeradbiomed.2017.04.015","article-title":"Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system","volume":"108","author":"Lee","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/dmd.124.001844_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/molpharm.120.000020","article-title":"Tyrosine nitration contributes to nitric oxide-stimulated degradation of CYP2B6","volume":"98","author":"Lee","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/11319980-000000000-00000","article-title":"CYP-mediated therapeutic protein-drug interactions: clinical findings, proposed mechanisms and regulatory implications","volume":"49","author":"Lee","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.124.001844_bib33","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0006-2952(02)01423-5","article-title":"Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: independence from nitric oxide production by inducible nitric oxide synthase","volume":"64","author":"Li-Masters","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1742-7843.2009.00405.x","article-title":"The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction","volume":"105","author":"Ling","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.124.001844_bib35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0006-291X(87)91422-7","article-title":"Growth hormone regulates expression of rat liver cytochrome P-450 15 beta at a pretranslational level","volume":"143","author":"MacGeoch","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.124.001844_bib36","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/endo-117-5-2085","article-title":"Hypothalamo-pituitary regulation of cytochrome P-450(15) beta apoprotein levels in rat liver","volume":"117","author":"MacGeoch","year":"1985","journal-title":"Endocrinology"},{"key":"10.1124\/dmd.124.001844_bib37","doi-asserted-by":"crossref","first-page":"15433","DOI":"10.1016\/S0021-9258(17)42567-1","article-title":"Purification, characterization, and pituitary regulation of the sex-specific cytochrome P-450 15 beta-hydroxylase from liver microsomes of untreated female rats","volume":"259","author":"MacGeoch","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.124.001844_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12936-019-2860-5","article-title":"A non-lethal malarial infection results in reduced drug metabolizing enzyme expression and drug clearance in mice","volume":"18","author":"Mimche","year":"2019","journal-title":"Malar J"},{"key":"10.1124\/dmd.124.001844_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/dmd.113.054957","article-title":"Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection","volume":"42","author":"Mimche","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001844_bib40","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1210\/endo-111-5-1692","article-title":"Association between plasma level of growth hormone and sex differentiation of hepatic steroid metabolism in the rat","volume":"111","author":"Mode","year":"1982","journal-title":"Endocrinology"},{"key":"10.1124\/dmd.124.001844_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0026-895X(25)09656-7","article-title":"Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin","volume":"36","author":"Morgan","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0006-2952(91)90680-4","article-title":"Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC","volume":"42","author":"Morgan","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0006-2952(93)90078-B","article-title":"Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis","volume":"45","author":"Morgan","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0006-2952(81)90131-3","article-title":"Changes in the rat hepatic mixed function oxidase system associated with chronic ethanol vapor inhalation","volume":"30","author":"Morgan","year":"1981","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib45","doi-asserted-by":"crossref","first-page":"13951","DOI":"10.1016\/S0021-9258(19)45325-8","article-title":"Catalytic activity of cytochrome P-450 isozyme 3a isolated from liver microsomes of ethanol-treated rabbits. Oxidation of alcohols","volume":"257","author":"Morgan","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.124.001844_bib46","doi-asserted-by":"crossref","first-page":"11895","DOI":"10.1016\/S0021-9258(17)38963-9","article-title":"Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16 alpha-hydroxylase cytochrome P-450 apoprotein in the rat","volume":"260","author":"Morgan","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.124.001844_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0026-895X(25)12386-9","article-title":"Sexual differentiation of cytochrome P-450 in rat liver. Evidence for a constitutive isozyme as the male-specific 16 alpha-hydroxylase","volume":"27","author":"Morgan","year":"1985","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib48","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0090-9556(25)08618-0","article-title":"Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers","volume":"18","author":"Morgan","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001844_bib49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/03602532.2020.1817061","article-title":"Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease","volume":"52","author":"Morgan","year":"2020","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.124.001844_bib50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0167-4781(94)90074-4","article-title":"Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver","volume":"1219","author":"Morgan","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.124.001844_bib51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(84)90030-8","article-title":"Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver","volume":"36","author":"Norstedt","year":"1984","journal-title":"Cell"},{"key":"10.1124\/dmd.124.001844_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.27","article-title":"Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: Implications for disease-dependent drug-drug interactions","volume":"2","author":"Nyagode","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/dmd.124.001844_bib53","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1124\/jpet.110.171488","article-title":"Modulation of Hepatic Cytochrome P450s by Citrobacter rodentium Infection in Interleukin-6- and Interferon-{gamma}-Null Mice","volume":"335","author":"Nyagode","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001844_bib54","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1124\/dmd.112.046557","article-title":"Selective modulation of hepatic cytochrome P450 and flavin monooxygenase 3 expression during citrobacter rodentium infection in severe combined immune-deficient mice","volume":"40","author":"Nyagode","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001844_bib55","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10753-013-9809-6","article-title":"Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes","volume":"37","author":"Nyagode","year":"2014","journal-title":"Inflammation"},{"key":"10.1124\/dmd.124.001844_bib56","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1042\/BCJ20170459","article-title":"Nitric oxide stimulates cellular degradation of human CYP51A1, the highly conserved lanosterol 14alpha-demethylase","volume":"474","author":"Park","year":"2017","journal-title":"Biochem J"},{"key":"10.1124\/dmd.124.001844_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.freeradbiomed.2018.04.576","article-title":"Posttranslational regulation of CYP2J2 by nitric oxide","volume":"121","author":"Park","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/dmd.124.001844_bib58","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0026-895X(25)13539-6","article-title":"Effects of polyribonoinosinic acid polyribocytidylic acid and a mouse interferon preparation on cytochrome P-450-dependent monooxygenase systems in cultures of primary mouse hepatocytes","volume":"14","author":"Renton","year":"1978","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-291X(76)90713-0","article-title":"Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents","volume":"73","author":"Renton","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.124.001844_bib60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.105.085456","article-title":"Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice","volume":"314","author":"Richardson","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001844_bib61","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/dmd.105.007393","article-title":"Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice","volume":"34","author":"Richardson","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001844_bib600","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1124\/dmd.105.007435","article-title":"Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney","volume":"34","author":"Richardson","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001844_bib62","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/clpt.2011.35","article-title":"Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis","volume":"89","author":"Schmitt","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001844_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00916041","article-title":"Levels of messenger ribonucleic acids for plasma proteins in rat liver during acute experimental inflammation","volume":"10","author":"Schreiber","year":"1986","journal-title":"Inflammation"},{"key":"10.1124\/dmd.124.001844_bib64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/mol.54.2.273","article-title":"Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene","volume":"54","author":"Sewer","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib65","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0022-3565(24)36526-7","article-title":"Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression","volume":"280","author":"Sewer","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001844_bib66","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0006-2952(97)00226-8","article-title":"Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes","volume":"54","author":"Sewer","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib67","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-3565(24)37797-3","article-title":"Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production","volume":"287","author":"Sewer","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001844_bib68","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/dmd.114.061093","article-title":"Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine","volume":"43","author":"Shah","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001844_bib69","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/0024-3205(87)90506-6","article-title":"Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice","volume":"40","author":"Shedlofsky","year":"1987","journal-title":"Life Sci"},{"key":"10.1124\/dmd.124.001844_bib70","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0026-895X(25)14394-0","article-title":"Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation","volume":"20","author":"Singh","year":"1981","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib71","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/0006-2952(80)90008-8","article-title":"The effects of gonadectomy and hypophysectomy on the metabolism of imipramine and lidocaine by the liver of male and female rats","volume":"29","author":"Skett","year":"1980","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib72","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1073\/pnas.91.9.3559","article-title":"Inhibition of cytochromes P4501A by nitric oxide","volume":"91","author":"Stadler","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.124.001844_bib73","first-page":"314","article-title":"Cloning and pretranslational hormonal regulation of testosterone 16 alpha-hydroxylase (P-45016 alpha) in male rat liver","volume":"118","author":"Str\u00f6m","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1124\/dmd.124.001844_bib74","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/17425255.2023.2228680","article-title":"The impact of COVID-19 infection on cytochrome P450 3A4-mediated drug metabolism and drug interactions","volume":"19","author":"Villemure","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.124.001844_bib75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-5793(90)80371-O","article-title":"Transcriptional and post-transcriptional suppression of P450IIC11 and P450IIC12 by inflammation","volume":"271","author":"Wright","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.124.001844_bib76","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0026-895X(25)11013-4","article-title":"Regulation of cytochrome P450IIC12 expression by interleukin-1 alpha, interleukin-6, and dexamethasone","volume":"39","author":"Wright","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.124.001844_bib77","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1159\/000495087","article-title":"Mice Deficient in Cyp4a14 Have An Increased Number of Goblet Cells and Attenuated Dextran Sulfate Sodium-Induced Colitis","volume":"50","author":"Xuan","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1124\/dmd.124.001844_bib78","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.103341.109","article-title":"Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver","volume":"20","author":"Yang","year":"2010","journal-title":"Genome Res"},{"key":"10.1124\/dmd.124.001844_bib79","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1073\/pnas.1700172114","article-title":"Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562415903X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562415903X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.124.001844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T07:56:21Z","timestamp":1740038181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562415903X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":80,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S009095562415903X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.124.001844","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shining a Light on Inflammation as a Critical Modulator of Drug Metabolism","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.124.001844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}